Renaissance Technologies
HIMS icon

Renaissance Technologies’s Hims & Hers Health HIMS Stock Holding History

Renaissance Technologies’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,118,080
Closed -$44M – 3376
2026
Q1 		$44M Sell
2,118,080
-2,699,929
-56% -$63.8M 0.07% 359
2025
Q4 		$156M Sell
4,818,009
-4,278,843
-47% -$183M 0.24% 88
2025
Q3 		$516M Buy
9,096,852
+2,227,400
+32% +$114M 0.68% 14
2025
Q2 		$342M Sell
6,869,452
-154,900
-2% -$7M 0.46% 27
2025
Q1 		$208M Buy
7,024,352
+73,200
+1% +$2.72M 0.31% 44
2024
Q4 		$168M Buy
6,951,152
+1,562,302
+29% +$38.7M 0.25% 71
2024
Q3 		$99.3M Sell
5,388,850
-650,558
-11% -$11.6M 0.15% 144
2024
Q2 		$122M Buy
6,039,408
+3,205,108
+113% +$53.3M 0.21% 94
2024
Q1 		$43.8M Buy
2,834,300
+2,184,127
+336% +$24.6M 0.07% 342
2023
Q4 		$5.79M Sell
650,173
-684,427
-51% -$5.06M 0.01% 1264
2023
Q3 		$8.39M Buy
1,334,600
+52,200
+4% +$388K 0.01% 1022
2023
Q2 		$12.1M Sell
1,282,400
-288,400
-18% -$2.86M 0.02% 929
2023
Q1 		$15.6M Buy
1,570,800
+62,100
+4% +$544K 0.02% 857
2022
Q4 		$9.67M Sell
1,508,700
-6,100
-0.4% -$34.7K 0.01% 1102
2022
Q3 		$8.45M Sell
1,514,800
-444,300
-23% -$2.68M 0.01% 1125
2022
Q2 		$8.88M Buy
1,959,100
+276,500
+16% +$1.18M 0.01% 1172
2022
Q1 		$8.97M Buy
1,682,600
+624,127
+59% +$3.09M 0.01% 1189
2021
Q4 		$6.93M Sell
1,058,473
-520,927
-33% -$3.77M 0.01% 1298
2021
Q3 		$11.9M Buy
1,579,400
+1,561,900
+8,925% +$13.2M 0.02% 928
2021
Q2 		$191K Buy
+17,500
New +$208K ﹤0.01% 3255

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Renaissance Technologies's HIMS Position: Q2 2026 in Review

Renaissance Technologies sold out of Hims & Hers Health (HIMS) in Q2 2026, closing a stake of 2,118,080 shares — an estimated $44M sold.

Renaissance Technologies first reported a position in HIMS in Q2 2021 and held it in 20 quarters. The position peaked at $516M in Q3 2025. 378 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Renaissance Technologies reported no remaining Hims & Hers Health position as of Q2 2026 after selling out during the quarter.
  • Renaissance Technologies sold 2,118,080 Hims & Hers Health shares in Q2 2026, an estimated $44M.
  • Renaissance Technologies first reported a position in Hims & Hers Health in Q2 2021 and held it in 20 quarters.
  • Renaissance Technologies's Hims & Hers Health position peaked at $516M in Q3 2025.
  • 378 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.